Roundup: Websites become more vulnerable to lawsuits, Meevee looks for buyers, and more
Here’s the latest action:
Rulings could make website owners more vulnerable to lawsuits — Decisions made by judges in two separate cases, against Friendfinder.com and Roommates.com, could expose websites to potentially harmful lawsuits, according to an article on CNET. Websites were previously immune to most lawsuits… Continue Reading
J.D. Power snaps up Umbria, a reputation tracker
J.D. Power, like Nielsen, is one of the old-line firms that has been telling companies how they are perceived by the public for decades. Both companies have been scrambling to get a hold on the Internet, which provides more opinions than a proctology practice.
Umbria, which… Continue Reading
Life-science briefing: Wednesday, March 19, 2008
TODAY’S HEADLINES:
Paris-based Stentys takes $18M for “bifurcated” stents (release)
Blood analyzer IntelliDx raises $22M (PDF release)
Cancer-test biotech Calderome changes name to VeraCyte (VentureWire)
Predictive Biosciences names Peter Klemm as CEO (release)
Paris-based Stentys takes $18M for “bifurcated” stents – Stentys, a Paris-based medical device maker, raised $18 million in… Continue Reading
Buzzwire, streaming media for mobile phones, raises $8 million
Buzzwire, which streams video and radio to mobile phones without the need for a download, has raised $8 million in its second round of financing.
The Boston-based company, which we wrote about here, says it has secured a distribution deal with one of the top U.S…. Continue Reading
HelioVolt raises $101M — biggest solar investment yet?
HelioVolt, one of about ten companies racing to produce solar power cells based new cheaper material than traditional silicon, has raised $24 million more in financing for a its second round.
This brings the Austin, Texas’ company’s total second round to a huge $101 million, making… Continue Reading
Life sciences briefing: Wednesday, Sept. 26, 2007
Featured companies: Ablynx, Cardiosolutions, Carigent Thereapeutics, Elusys, Genome Corp., GlobeImmune, Novazone, Targanta Therapeutics, Waterfront Media
UPDATED at 5:45am on 9/27/07
GlobeImmune raises $41M for immune-system therapies — GlobeImmune, a Louisville, Colo., biotech focused on new forms of immunotherapy to treat viral infections and cancer, raised $41.2 million in… Continue Reading